| Category: |
Antibody |
| Concentration: |
pH7, with 0, 02% sodium azide, 3, 5 mg/ml in 1X TBS, 5% BSA (US sourced) and 0 |
| Form: |
Antigen affinity purified |
| Conjugation: |
Unconjugated |
| Clone: |
Polyclonal antibody |
| Recognised antigen: |
NFATC3 |
| Host animal: |
Goat (Capra aegagrus hircus) |
| Clonality: |
Polyclonal (goat origin) |
| Species reactivity: |
Due to limited knowledge and inability to test the antibody against all known species, we cannot guarantee that no other cross reactivity can occur, Human (Homo sapiens) |
| Tested applications: |
ELISA (peptide), WB |
| Recommended dilutions: |
0ug/ml, 3-1, ELISA (peptide) LOD: 1:16000, Western blot: 0 |
| Notes: |
Optimal dilution of the NFATC3 antibody should be determined by the researcher |
| Intented use: |
This NFATC3 antibodyis to be used only for research purposes and not for diagnostics |
| Gene ID #: |
4775 |
| Purity: |
Antigen affinity |
| Description: |
NFAT4, calcineurin-dependent 3, cytoplasmic, Additional name(s) for this target protein: Nuclear factor of activated T-cells |
| Immunogen: |
Amino acids HQELDAHEDDLQIN were used as the immunogen for this NFATC3 antibody |
| Storage: |
Celcius or lower, Cycles of freezing and thawing can denaturate the peptide chains of the antibodies and reduce their sensitivity and/or change their affinity, Prepare aliqotes in such a manner so that freeze-thaw cycles are minimized, Aliquot and store the NFATC3 antibody at -20 deg |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by NJS poly they should be stored frozen at - 24° |
| Gene target: |
NFATC3 |
| Short name: |
NFATC3 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
calcineurin-dependent 3 (Antibody to), cytoplasmic, nuclear factor on activated T-cells |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
BT, DNA-templated and biological process this GO :0006357 and regulation of transcription from RNA polymerase II promoter and biological process this GO :0006366 and transcription from RNA polymerase II promoter and biological process this GO :0006954 and inflammatory response and biological process this GO :0007507 and heart development and biological process this GO :0038095 and Fc-epsilon receptor signaling pathway and biological process this GO :0045087 and innate immune response and biological process this GO :0045333 and cellular respiration and biological process this GO :0045893 and positive regulation of transcription, DNA-templated and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0051145 and smooth muscle cell differentiation and biological process this GO :0055001 and muscle cell development and biological process this GO :0071277 and cellular response to calcium ion and biological process this GO :0071285 and cellular response to lithium ion and biological process, NFAT4 and NFATX, NFATC3 and IDBG-38028 and ENSG00000072736 and 4775, Nfatc3 and IDBG-189544 and ENSMUSG00000031902 and 18021, calcineurin-dependent 3, cytoplasmic, nuclei, protein binding, this GO :0000978 and RNA polymerase II core promoter proximal region sequence-specific DNA binding and molecular function this GO :0001077 and RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription and molecular function this GO :0001569 and patterning of blood vessels and biological process this GO :0003677 and DNA binding and molecular function this GO :0003682 and chromatin binding and molecular function this GO :0003700 and sequence-specific DNA binding transcription factor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005654 and nucleoplasm and cellular component this GO :0005730 and nucleolus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005829 and cytosol and cellular component this GO :0006355 and regulation of transcription, this GO :0000978 : RNA polymerase II core promoter proximal region sequence-specific DNA binding, this GO :0000978 : RNA polymerase II core promoter proximal region sequence-specific DNA binding and also this GO :0001077 : RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription and also this GO :0003677 : DNA binding and also this GO :0003682 : chromatin binding and also this GO :0003700 : sequence-specific DNA binding transcription factor activity and also this GO :0005515 : protein binding, this GO :0001077 : RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription, this GO :0003677 : DNA binding, this GO :0003682 : chromatin binding, this GO :0003700 : sequence-specific DNA binding transcription factor activity, this GO :0005515 : protein binding, 105181 and IDBG-634110 and ENSBTAG00000004368 and 541127, nuclear factor of activated T-cells |
| Identity: |
7777 |
| Gene: |
NFATC3 |
More about : NFATC3 |
| Long gene name: |
nuclear factor of activated T-cells 3 |
| Synonyms gene name: |
calcineurin-dependent 3 , cytoplasmic, nuclear factor of activated T-cells |
| Synonyms: |
NFAT4 NFATX |
| Locus: |
16q22, 1 |
| Discovery year: |
1994-11-16 |
| GenBank acession: |
L41067 |
| Entrez gene record: |
4775 |
| Pubmed identfication: |
7749981 |
| RefSeq identity: |
NM_004555 |
| Classification: |
Nuclear factors of activated T-cells |
| Havana BLAST/BLAT: |
OTTHUMG00000137555 |